Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes

Gary S. Francis; Matthew T. Roe; Shelly K. Sapp; A. Michael Lincoff

Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes

Gary S. Francis, MD
Gary S. Francis
MD
Matthew T. Roe, MD
Matthew T. Roe
Division of Cardiology, Duke Clinical Research Institute
MD
Shelly K. Sapp, MS
Shelly K. Sapp
Senior blostatistician, Cleveland Clinic Cardiovascular Coordinating Center
MS
and A. Michael Lincoff, MD
A. Michael Lincoff
Director, Experiental Interventional Laboratory Department of Cardiology, Cleveland Clinic
MD
Roles: Editor of Glycoprotein llblllla Inhibitors in Cardiovascular Diseases
- Find this author on Google Scholar
- Find this author on PubMed
- Search for this author on this site
- For correspondence: [email protected]

Cleveland Clinic Journal of Medicine
February 2000,
67
(2)
131-140;

ABSTRACT

Glycoprotein (GP) Ilb/IIIa inhibitors are potent antiplatelet agents and represent an exciting breakthrough in the treatment of acute coronary syndromes. However, their safety and cost-effectiveness require further investigation, and more information on risk stratification is needed to clarify which patients benefit the most from empiric use of these agents.

PDF

Previous Next

In this issue

Print
Download PDF
Article Alerts

Alerts for this Article

User Name *

Password *

Sign In to Email Alerts with your Email Address
Email *
Email Article

Email This Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.
Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following
Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
Message Subject
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine

Message Body
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Citation Tools
Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes

Gary S. Francis

Gary S. Francis

Matthew T. Roe

Matthew T. Roe

Shelly K. Sapp

Shelly K. Sapp

and A. Michael Lincoff

A. Michael Lincoff

Cleveland Clinic Journal of Medicine

February 2000,

67

(2)

131-140;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Share
Share This Article
Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes

Gary S. Francis

Gary S. Francis

Matthew T. Roe

Matthew T. Roe

Shelly K. Sapp

Shelly K. Sapp

and A. Michael Lincoff

A. Michael Lincoff

Cleveland Clinic Journal of Medicine

February 2000,

67

(2)

131-140;

Share This Article:
Post